Retzius-sparing robot-assisted radical prostatectomy after previous trans-urethral resection of the prostate: Assessment of functional and oncological outcomes.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date: Mar 16, 2023

Abstract

BACKGROUND: no data exist concerning functional and oncological outcomes of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP), in patients previously treated with trans-urethral resection of the prostate (p-TURP), for benign prostate obstruction. Our study addressed the impact of p-TURP on immediate and 12-months urinary continence recovery (UCR), as well as peri-operative outcomes and surgical margins, after RS-RARP.

Authors

  • Stefano Tappero
    Department of Urology, San Martino Hospital, University of Genoa, Genoa, Italy.
  • Enrico Vecchio
    Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Erika Palagonia
    School of Medicine, Division of Urology, Department of Clinical, Special and Dental Sciences, University Hospital "Ospedali Riuniti", Marche Polytechnic University, Ancona, Italy.
  • Mattia Longoni
    Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Marco Martiriggiano
    Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Giorgia Granelli
    Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Urology, IRCCS Ospedale Policlinico San Martino, University of Genova, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Alberto Olivero
    Urology Unit, Niguarda Hospital, Milan, Italy; Department of Urology, San Martino Policlinico Hospital, IRCCS for Oncology, Genoa, Italy.
  • Silvia Secco
    Department of Urology. ASST Grande Ospedale Metropolitano Niguarda. Milan. Italy.
  • Aldo Massimo Bocciardi
    Department of Urology, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Antonio Galfano
    Department of Urology, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.

Keywords

External Resources

Popular Topics
Recent Journals